Latest Scrip World Pharmaceutical News Stories
ABBOTT PARK, Ill., Nov.
NEW YORK, September 27, 2010 /PRNewswire/ -- Scrip, the market-leading international pharmaceutical and biotech information provider, has appointed Christopher Bowe to the post of US Healthcare Analyst as part of its expansion of an analyst team to serve subscribers. With his appointment, Bowe will help expand the high-value original and topical analysis of pharmaceutical and healthcare industries, policy and regulation, as well as engage and serve customers through Scrip's tailored...
London, Aug 11, 2010 - (ACN Newswire) - Scrip has published the first edition of the Scrip Asia 100 - its comprehensive analysis of the pharmaceutical industry's performance and prospects in Asia.
LEUVEN, Belgium, September 11 /PRNewswire-FirstCall/ -- - ThromboGenics' Significant Achievements Over the Last Year are Recognised in Nominations ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announced today that it has been shortlisted for both the "Biotech Company of the Year" and "Licensing Deal of the Year" awards at the Scrip Awards 2009.
BOSTON, Dec. 15 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has been named the "Best Contract Research Organization (CRO)" by Scrip World Pharmaceutical News.
China's State Council has published a white paper that reviewed the overall progress achieved in the pharmaceutical industry.
Pharma companies can no longer depend on incremental changes to secure their future but should decide on what they want to focus on, for example, whether to continue to serve a large market base or mobilize resources for developing specialty treatments, Scrip World Pharmaceutical News has said quoting a PricewaterhouseCoopers report.
RALEIGH, N.C., July 8 /PRNewswire/ -- Pharmaceutical Institute, a subsidiary of Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced the release of a revised edition of "Understanding Pharma", updated to reflect a dynamic market environment and offering key new insights on how pharmaceutical and biotechnology companies work.